<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 09 Testing for Illegal Use of Drugs | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/17.04.09/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/17.04.09/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|17|04|09|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="doc-num" content="09"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="17|04|09" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/17.04.09"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 09 Testing for Illegal Use of Drugs | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/17.04.09/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/17.04.09/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|17" data-search-heading="">
                  <a href="/us/md/exec/comar/17" title="Title 17 DEPARTMENT OF BUDGET AND MANAGEMENT">Title 17 DEPARTMENT OF BUDGET AND MANAGEMENT</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|17|04" data-search-heading="">
                  <a href="/us/md/exec/comar/17.04" title="Subtitle 04 PERSONNEL SERVICES AND BENEFITS">Subtitle 04 PERSONNEL SERVICES AND BENEFITS</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|17|04|09" data-search-heading="">
                  <span title="Chapter 09 Testing for Illegal Use of Drugs">Chapter 09 Testing for Illegal Use of Drugs</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="17|04|09">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/17.04.09">Chapter 09 Testing for Illegal Use of Drugs</h1>
                <section class="line-group annotations">
                  <h2>Administrative History</h2>
                  <p>Effective date: January 9, 1989 (15:27 Md. R. 3126)</p>
                  <p>Regulations .01, .03—.11, .13, and .14 amended effective August 6, 1990 (17:15 Md. R. 1854)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/17.04.09.01#B" title="">Regulation .01B</a> amended effective October 24, 1994 (21:21 Md. R. 1812)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/17.04.09.02-1" title=".02-1 Designation of Sensitive Positions by Appointing Authority.">Regulation .02-1</a> adopted effective August 6, 1990 (17:15 Md. R. 1854)</p>
                  <p>Regulations .03E, .04E, .10A, B, and .14B amended, and .04F and .14C adopted as an emergency provision effective November 20, 1990 (17:26 Md. R. 2972); adopted permanently May 13, 1991 (18:9 Md. R. 1007)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/17.04.09.03#E" title="">Regulation .03E</a> amended as an emergency provision effective May 24, 1993 (20:12 Md. R. 994); emergency status expired November 30, 1993; adopted permanently effective March 28, 1994 (21:6 Md. R. 465)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/17.04.09.04" title=".04 Requirements for Employees.">Regulation .04</a> amended effective October 24, 1994 (21:21 Md. R. 1812)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/17.04.09.08#A" title="">Regulation .08A</a> amended effective October 24, 1994 (21:21 Md. R. 1812)</p>
                  <p>——————</p>
                  <p>For a history of State Personnel Regulations before February 12, 1997, see the prior version of COMAR Title 06 or contact the Maryland State Archives for assistance</p>
                  <h2>Authority</h2>
                  <p>Executive Order 01.01.1991.16; State Personnel and Pensions Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsp&amp;section=4-103" title="">4-103</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsp&amp;section=4-106" title="">4-106</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsp&amp;section=4-201" title="">4-201</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsp&amp;section=4-203" title="">4-203</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsp&amp;section=4-303" title="">4-303</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsp&amp;section=4-307" title="">4-307</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsp&amp;section=4-501" title="">4-501</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsp&amp;section=4-504" title="">4-504</a>, and Title 9; Annotated Code of Maryland</p>
                </section>
                <h2 id="/us/md/exec/comar/17.04.09.01" data-order="|17|04|09|.01|" data-ref-path="17|04|09|.01" class="h__section">.01 Definitions.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(1)">(1)</span> "Agency technical representative" means an employee designated by an appointing authority to ensure compliance with the requirements of this chapter and whose duties include, but are not limited to, the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(1)(a)">(a)</span> Scheduling of urine specimen collections;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(1)(b)">(b)</span> Designation of collection sites;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(1)(c)">(c)</span> Assurance of integrity of collection procedures and sites;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(1)(d)">(d)</span> Assurance of integrity of testing and specimen retention procedures;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(1)(e)">(e)</span> Review of data and reports; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(1)(f)">(f)</span> Acting as contact person for the appointing authority's program for testing for illegal use of drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(2)">(2)</span> "Applicant" means a person who is seeking an employer-employee relationship in a position in a sensitive classification or in a sensitive position.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(3)">(3)</span> "Applicant-employee" means an employee of the State who is an applicant for a position that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(3)(a)">(a)</span> In a sensitive classification or is a sensitive position; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(3)(b)">(b)</span> Different from or in addition to the position currently held by the applicant-employee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(4)">(4)</span> "Appointing authority" means a person who has the power to make appointments and to terminate employment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(4-1)">(4-1)</span> "Controlled dangerous substance offense" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(4-1)(a)">(a)</span> A controlled dangerous substance violation under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gcr/gcr.pdf" title="">Criminal Law Article, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(4-1)(b)">(b)</span> An offense of the law of any other jurisdiction if the prohibited conduct is a controlled dangerous substance offense if committed in this State; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(4-1)(c)">(c)</span> Driving or attempting to drive while under the influence of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(4-1)(c)(i)">(i)</span> Drugs or drugs and alcohol, or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(4-1)(c)(ii)">(ii)</span> A controlled dangerous substance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(5)">(5)</span> "Employee" means a person with whom the State has an employer-employee relationship.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)">(6)</span> "Employer-employee relationship" means a relationship in which a person is paid for services to the State and in which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(a)">(a)</span> All of the following conditions of employment exist:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(a)(i)">(i)</span> The State has the right to control and direct the performance of services not only as to results, but also as to details and means,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(a)(ii)">(ii)</span> The State has the right to discharge the employee, and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(a)(iii)">(iii)</span> The State furnishes necessary tools and a place to work;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(b)">(b)</span> The status of the employee is any of the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(b)(i)">(i)</span> Classified,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(b)(ii)">(ii)</span> Unclassified,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(b)(iii)">(iii)</span> Temporary extra, or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(b)(iv)">(iv)</span> Contractual; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)">(c)</span> Any of the following personnel actions resulted in employment:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(i)">(i)</span> Open selection from an eligible list,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(ii)">(ii)</span> Promotion,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(iii)">(iii)</span> Demotion,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(iv)">(iv)</span> Horizontal change,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(v)">(v)</span> Transfer,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(vi)">(vi)</span> Reinstatement,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(vii)">(vii)</span> Reemployment,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(viii)">(viii)</span> Reclassification,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(ix)">(ix)</span> Unclassified appointment,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(x)">(x)</span> Temporary appointment pending examination,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(xi)">(xi)</span> Temporary extra appointment, or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(6)(c)(xii)">(xii)</span> Contractual appointment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(7)">(7)</span> "Secretary" means the Secretary of Budget and Management or the Secretary's designated representative.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(8)">(8)</span> "Sensitive classification" means a classification in which the Secretary has determined that any of the following conditions exists:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(8)(a)">(a)</span> An employee in the classification has a substantially significant degree of responsibility for the safety of others and there is a potential that impaired performance of the employee could result in death of or injury to the employee or others;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(8)(b)">(b)</span> An employee in the classification is required to carry a firearm;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(8)(c)">(c)</span> An employee in the classification is directly involved in efforts to interdict the flow of narcotics; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(8)(d)">(d)</span> An employee in the classification is directly involved with narcotics law enforcement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.01#B(9)">(9)</span> "Sensitive position" means a position for which an appointing authority has determined that any of the conditions listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.01#B(8)" title="">§B(8) of this regulation</a> exists, but which is not in a sensitive classification.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.02" data-order="|17|04|09|.02|" data-ref-path="17|04|09|.02" class="h__section">.02 List of Sensitive Classifications.</h2>
                <p>The Secretary shall maintain a list of sensitive classifications.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.02-1" data-order="|17|04|09|.02-1|" data-ref-path="17|04|09|.02-1" class="h__section">.02-1 Designation of Sensitive Positions by Appointing Authority.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.02-1#A">A.</span> Each appointing authority is responsible for determining whether positions within the appointing authority are sensitive, and may designate those positions as sensitive positions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.02-1#B">B.</span> Each appointing authority who designates a position as sensitive shall be responsible for all of the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.02-1#B(1)">(1)</span> Notification to the employee in the position of the designation of the position as sensitive and of requirements for testing in accordance with <a class="internal-link " href="/us/md/exec/comar/17.04.09.04" title=".04 Requirements for Employees.">Regulation .04 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.02-1#B(2)">(2)</span> Maintenance of documentation of the reasons for the designation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.02-1#B(3)">(3)</span> Presentation of the reasons for the designation in administrative or judicial proceedings; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.02-1#B(4)">(4)</span> Provision of reports to the Secretary, to be submitted following the end of each fiscal quarter, listing each position, as identified by position identification number, that has been designated as sensitive along with the reasons for the designation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.03" data-order="|17|04|09|.03|" data-ref-path="17|04|09|.03" class="h__section">.03 Requirements for Applicants for Positions in Sensitive Classifications or for Sensitive Positions.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#A">A.</span> In addition to applicants, §§B—E of this regulation apply to applicant-employees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#B">B.</span> Conditions for Testing. Testing for illegal use of drugs shall be required for positions in sensitive classifications or for sensitive positions if the applicant has not been eliminated from consideration at an earlier stage of the recruitment process.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#C">C.</span> Notification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#C(1)">(1)</span> Examination Announcements; Information Provided by Appointing Authority. Examination announcements for positions in sensitive classifications shall include a statement that testing for illegal use of drugs is part of the selection process. The appointing authority shall also inform applicants for positions in sensitive classifications or for sensitive positions that testing for illegal use of drugs is required and shall be conducted at some point in the selection process, including any time during the applicant's probationary period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#C(2)">(2)</span> Refusal to be Tested. The appointing authority shall inform an applicant for a position in a sensitive classification or for a sensitive position who refuses to be tested that refusal shall result in all of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#C(2)(a)">(a)</span> Disqualification from that position;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#C(2)(b)">(b)</span> Removal from any list of eligibles for any sensitive classification; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#C(2)(c)">(c)</span> Removal from the list of eligibles for all sensitive positions within the classification of the sensitive position for which the applicant refused to be tested.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#C(3)">(3)</span> Positive Test Results. The appointing authority shall inform an applicant who agrees to be tested of the consequences of a positive test result in accordance with <a class="internal-link " href="/us/md/exec/comar/17.04.09.03#E" title="">§E of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#D">D.</span> Testing Protocol.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#D(1)">(1)</span> The appointing authority shall give an applicant for a position in a sensitive classification or for a sensitive position who has not been eliminated from consideration at an earlier stage of the recruitment process a Drug Abuse Screen-Applicant Authorization form prescribed by the Secretary to complete at the interview. The applicant shall appear at one of the designated collection sites with the completed authorization form at a time set by the appointing authority. When urine specimen collection as provided in <a class="internal-link " href="/us/md/exec/comar/17.04.09.05" title=".05 Urine Specimen Collection; Chain of Custody; Retention of Specimen and Test Results.">Regulation .05 of this chapter</a> is a part of the interview, the urine specimen may be collected at the time of the interview.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#D(2)">(2)</span> After completion of the test, the test results shall be provided to the State Medical Director, who shall inform the appointing authority of the suitability of the applicant for further consideration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#D(3)">(3)</span> If the State Medical Director has determined that an applicant is suitable in accordance with <a class="internal-link " href="/us/md/exec/comar/17.04.09.03#D(2)" title="">§D(2) of this regulation</a>, the appointing authority shall schedule an appointment for the applicant to appear for a physical examination within 8 calendar days after the date of the interview.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#D(4)">(4)</span> All testing protocols shall be in accordance with <a class="internal-link " href="/us/md/exec/comar/17.04.09.05" title=".05 Urine Specimen Collection; Chain of Custody; Retention of Specimen and Test Results.">Regulation .05 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E">E.</span> Consequences of Positive Test Results.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(1)">(1)</span> An applicant for a position in a sensitive classification or for a sensitive position who tests positive shall be disqualified from State employment for a position in a sensitive classification or for a sensitive position unless the applicant submits to the Secretary a certificate from a physician certifying on the certificate under oath that the applicant has:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(1)(a)">(a)</span> Successfully participated in a drug abuse rehabilitation program of at least 6 months duration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(1)(b)">(b)</span> Been free of drugs listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.06" title=".06 Drugs to be Screened.">Regulation .06 of this chapter</a> for at least 18 months immediately before reapplying for State service.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(2)">(2)</span> An applicant who is later hired in accordance with the procedure described in <a class="internal-link " href="/us/md/exec/comar/17.04.09.03#E(1)" title="">§E(1) of this regulation</a> shall be subject to periodic random testing for illegal use of drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(3)">(3)</span> Positive Test Applicant-Employee.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(3)(a)">(a)</span> If an applicant-employee for a position in a sensitive classification or a sensitive position tests positive for use of illegal drugs, as part of a personnel selection process involving a promotion, demotion, horizontal change, transfer, or reclassification, the State Medical Director shall notify the applicant-employee's appointing authority of the positive test result.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(3)(b)">(b)</span> The appointing authority shall suspend the employee in <a class="internal-link " href="/us/md/exec/comar/17.04.09.03#E(3)(a)" title="">§E(3)(a) of this regulation</a>, without pay for 15 work days. As a condition of returning to work, the employee shall enroll in a drug abuse rehabilitation program of at least 6 months duration and shall be subject to periodic testing throughout the duration of the program. At the conclusion of the rehabilitation program the employee shall submit to the Secretary a certification from the attending physician, or a certified chemical dependency counselor, licensed certified social worker, or licensed psychologist associated with the rehabilitation program, certifying on the certificate under oath that the employee has successfully participated in a drug abuse program of at least 6 months duration and has not tested positive for drugs listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.06" title=".06 Drugs to be Screened.">Regulation .06 of this chapter</a> at any point during the rehabilitation program. If the employee does not enroll in a drug abuse rehabilitation program during the suspension period, or if the employee fails to successfully participate in a drug abuse rehabilitation program for at least 6 months, the appointing authority shall begin proceedings to dismiss the employee.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(3)(c)">(c)</span> The employee who successfully participated in a drug abuse rehabilitation program of at least 6 months duration and has been free of drugs listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.06" title=".06 Drugs to be Screened.">Regulation .06 of this chapter</a> for at least 18 months, including the 6-month period in which the employee participated in a drug abuse rehabilitation program, may reapply for a sensitive classification or a sensitive position.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(4)">(4)</span> A person who is later hired in accordance with the procedure described in <a class="internal-link " href="/us/md/exec/comar/17.04.09.03#E(3)" title="">§E(3) of this regulation</a> shall be subject to periodic random testing for illegal use of drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#E(5)">(5)</span> The State Medical Director may disapprove a physician's certificate as set forth in §E(1) and (3) of this regulation if the State Medical Director determines that the drug abuse rehabilitation program does not meet standards generally recognized in the field of drug abuse treatment or therapy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#F">F.</span> Appeal Rights.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#F(1)">(1)</span> This section applies to applicants only.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#F(2)">(2)</span> The appointing authority shall notify the applicant in writing of any disqualification based on test results, and shall inform the applicant of the appropriate appeal route.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#F(3)">(3)</span> An applicant may submit a written appeal of any positive test results to the Secretary within 5 work days after receipt of the written notice of the positive test results. The applicant shall bear the burden of proving an irregularity in the drug testing procedure used. This appeal may not be a contested case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#F(4)">(4)</span> Upon receipt of the appeal, the Secretary shall review the documentation, and may decide to uphold the decision of the appointing  authority to eliminate the applicant from consideration in accordance with <a class="internal-link " href="/us/md/exec/comar/17.04.09.03#E" title="">§E of this regulation</a> or:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#F(4)(a)">(a)</span> Conduct an investigation to obtain additional information; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#F(4)(b)">(b)</span> Convene a conference, which may be attended by the appointing authority, the applicant, and other appropriate individuals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.03#F(5)">(5)</span> The Secretary shall issue a written determination within 45 calendar days after receipt of the appeal, or within 45 calendar days after an investigation or conference.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.04" data-order="|17|04|09|.04|" data-ref-path="17|04|09|.04" class="h__section">.04 Requirements for Employees.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#A">A.</span> Employee Arrest. Each employee arrested for an alleged controlled dangerous substance offense shall report the arrest to the employee's appointing authority on the employee's next scheduled work day, or within 1 week, whichever is earlier. Failure to report the arrest shall result in disciplinary action, up to and including dismissal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#B">B.</span> Conditions for Testing for Illegal Use of Drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#B(1)">(1)</span> An appointing authority may require that an employee be tested if the appointing authority has reasonable suspicion to believe that the employee has illegally used drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#B(2)">(2)</span> An appointing authority may require employees in positions in sensitive classifications or in sensitive positions to be tested for the illegal use of drugs if any of the following conditions exist:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#B(2)(a)">(a)</span> Reasonable Suspicion. This condition exists when the appointing authority has reasonable and specific grounds to believe that a drug abuse test of an employee shall produce evidence of illegal use of drugs.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#B(2)(b)">(b)</span> Incident Triggered Factor. This condition exists when an injury to the employee or another person or property damage may have been caused by human error, and the employee was directly involved in the accident or incident.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#B(2)(c)">(c)</span> Participation in Drug Abuse Rehabilitation Program. This condition exists when an employee in a position in a sensitive classification or in a sensitive position has notified the employee's appointing authority that the employee is voluntarily participating in a drug abuse rehabilitation program, including any program offered under the State Employee Assistance Program, and this participation is not the result of having tested positive in accordance with this chapter. The employee's appointing authority may arrange for testing of the employee at any time during the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#B(2)(c)(i)">(i)</span> Employee's participation in the rehabilitation program; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#B(2)(c)(ii)">(ii)</span> One-year period immediately following the employee's successful completion of the rehabilitation program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#B(2)(d)">(d)</span> Arrest for a Controlled Dangerous Substance Offense. This condition exists when an employee in a position in a sensitive classification or in a sensitive position has notified the employee's appointing authority that the employee has been arrested for a controlled dangerous substance offense.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#C">C.</span> Random Testing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#C(1)">(1)</span> Each appointing authority, with the approval of the Secretary, shall assure that employees in positions in sensitive classifications or in sensitive positions within the appointing authority are subject to random testing for illegal use of drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#C(2)">(2)</span> Random testing requires that statistically significant samples of employees in sensitive classifications or in sensitive positions be tested on a periodic basis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#C(3)">(3)</span> All employees in sensitive classifications or in sensitive positions have an equal chance of being tested. However, only a sample of employees in each sensitive classification or a sample of all employees in sensitive positions are tested, based upon an appropriate random sampling technique.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#D">D.</span> Notification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#D(1)">(1)</span> An appointing authority shall give an employee who is to be tested a Controlled Dangerous Substance Test Order prescribed by the Secretary.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#D(2)">(2)</span> Refusal to be Tested. The appointing authority shall inform an employee who refuses to be tested that refusal may result in disciplinary action, which may include termination from State service.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#D(3)">(3)</span> Positive Test Results. The appointing authority shall inform an employee who agrees to be tested of the consequences of a positive test result in accordance with <a class="internal-link " href="/us/md/exec/comar/17.04.09.04#E" title="">§E of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#E">E.</span> Testing Protocol.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#E(1)">(1)</span> The appointing authority shall provide an employee who is ordered to take a urinalysis for the purpose of testing for illegal use of drugs with a Controlled Dangerous Substance Test Order.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#E(2)">(2)</span> After completion of the test, the test results shall be provided to the State Medical Director, who shall inform the appointing authority of whether an employee has tested positive or negative.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#E(3)">(3)</span> All testing protocols shall be in accordance with <a class="internal-link " href="/us/md/exec/comar/17.04.09.05" title=".05 Urine Specimen Collection; Chain of Custody; Retention of Specimen and Test Results.">Regulation .05 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F">F.</span> Consequences of Positive Test Results.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(1)">(1)</span> When, as a result of a random drug test in accordance with <a class="internal-link " href="/us/md/exec/comar/17.04.09.04#C" title="">§C of this regulation</a>, an employee in a position in a sensitive classification or in a sensitive position tests positive for use of illegal drugs, the appointing authority shall suspend the employee without pay for 15 work days. As a condition of returning to work, the employee shall enroll in a drug abuse rehabilitation program of at least 6 months duration and shall be subject to periodic testing throughout the duration of the program. At the conclusion of the rehabilitation program the employee shall submit to the Secretary a certification from the attending physician, or a certified chemical dependency counselor, licensed certified social worker, or licensed psychologist associated with the rehabilitation program, certifying on the certificate under oath that the employee has successfully participated in a drug abuse rehabilitation program of at least 6 months duration and has not tested positive for drugs listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.06" title=".06 Drugs to be Screened.">Regulation .06 of this chapter</a> at any point during the rehabilitation program. If the employee does not enroll in a drug abuse rehabilitation program during the suspension period, or if the employee fails to successfully participate in a drug abuse rehabilitation program for at least 6 months, the appointing authority shall begin proceedings to dismiss the employee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(2)">(2)</span> When, as the result of any of the conditions described in <a class="internal-link " href="/us/md/exec/comar/17.04.09.04#B(2)" title="">§B(2) of this regulation</a>, an employee in a position in a sensitive classification or in a sensitive position tests positive for use of illegal drugs, the appointing authority shall institute proceedings to dismiss the employee in accordance with the employee's status of employment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(3)">(3)</span> When an employee not in a position in a sensitive classification or not in a sensitive position tests positive, the appointing authority shall institute whatever disciplinary action the appointing authority considers appropriate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(4)">(4)</span> Drug Rehabilitation Program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(4)(a)">(a)</span> The employee's continued employment or eligibility for reemployment, if terminated, may be conditioned on the employee's enrollment in and satisfactory completion of a drug rehabilitation program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(4)(b)">(b)</span> If the employee is not terminated, the employee shall be required to enroll in a drug abuse rehabilitation program of at least 6 months duration and shall be subject to periodic testing throughout the duration of the program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(4)(c)">(c)</span> At the conclusion of the rehabilitation program the employee shall submit to the Secretary a certification from the attending physician, or a certified chemical dependency counselor, licensed certified social worker, or licensed psychologist associated with the rehabilitation program, certifying under oath that the employee has successfully participated in a drug abuse rehabilitation program of at least 6 months duration and has not tested positive for drugs listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.06" title=".06 Drugs to be Screened.">Regulation .06 of this chapter</a> at any point during the rehabilitation program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(4)(d)">(d)</span> The employee may be tested again at any point during the year following participation in the rehabilitation program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(4)(e)">(e)</span> If the employee does not enroll in the drug abuse rehabilitation program, or does not successfully complete the rehabilitation program, or if the employee tests positive at any point during the 1 year following participation in the rehabilitation program, the employee shall be terminated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(5)">(5)</span> An employee who is dismissed from State service in accordance with <a class="internal-link " href="/us/md/exec/comar/17.04.09.04#F(1)" title="">§F(1) of this regulation</a> shall be disqualified from State employment for positions in sensitive classifications or for sensitive positions unless the person submits to the Secretary a certificate from a physician certifying on the certificate under oath that the person has:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(5)(a)">(a)</span> Successfully participated in a drug abuse rehabilitation program of at least 6 months duration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(5)(b)">(b)</span> Been free of drugs listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.06" title=".06 Drugs to be Screened.">Regulation .06 of this chapter</a> for at least 18 months before the person's application for the position.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(6)">(6)</span> An individual who is later hired in accordance with the procedure described in <a class="internal-link " href="/us/md/exec/comar/17.04.09.04#F(5)" title="">§F(5) of this regulation</a> shall be subject to periodic testing for illegal use of drugs. If the individual tests positive, the individual shall be terminated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(7)">(7)</span> An individual who is later hired in accordance with the procedure described in <a class="internal-link " href="/us/md/exec/comar/17.04.09.04#F(5)" title="">§F(5) of this regulation</a> and who tests positive for illegal use of a controlled dangerous substance shall be dismissed from State service. The individual's eligibility for future State employment shall be conditioned on whatever terms the Secretary considers appropriate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(8)">(8)</span> The State Medical Director may disapprove a certificate as set forth in  §F(1) and (5) of this regulation if the State Medical Director determines that the drug abuse rehabilitation program does not meet standards generally recognized in the field of drug abuse treatment or therapy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#F(9)">(9)</span> Nothing in this section shall be interpreted to prevent an appointing authority from taking appropriate disciplinary action, which may include termination, against an employee when the employee's conduct provides independent grounds for disciplinary action.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.04#G">G.</span> Appeal Rights. An employee or an applicant-employee may submit a written appeal in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/17.04.07" title="Chapter 07 Conferences, Hearings, and Appeals">COMAR 17.04.07</a>. The adverse party in an appeal shall be the appointing authority.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.05" data-order="|17|04|09|.05|" data-ref-path="17|04|09|.05" class="h__section">.05 Urine Specimen Collection; Chain of Custody; Retention of Specimen and Test Results.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.05#A">A.</span> The appointing authority shall assure that all aspects of urine specimen collection are controlled to ensure integrity of the specimen. This includes either observation as the specimen is provided or methods to preclude adulteration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.05#B">B.</span> The appointing authority shall assure that a chain of custody is established consistent with forensic protocol standards. This means that the specimen is to be sealed in a special container and envelope which is signed by the individual being tested and by every other person who has custody until the specimen is delivered to the testing laboratory technician. All aspects of specimen receipt, identification, and testing shall be documented.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.05#C">C.</span> The laboratory that tests the specimen shall retain all confirmed positive test:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.05#C(1)">(1)</span> Specimens for 1 year or longer as may be required by the State; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.05#C(2)">(2)</span> Results for at least 3 years or longer as may be required by the State.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.06" data-order="|17|04|09|.06|" data-ref-path="17|04|09|.06" class="h__section">.06 Drugs to be Screened.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.06#A">A.</span> The drugs that shall be screened include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.06#A(1)">(1)</span> Marijuana/cannabinoids;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.06#A(2)">(2)</span> Cocaine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.06#A(3)">(3)</span> Opiates;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.06#A(4)">(4)</span> Phencyclidine (PCP); and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.06#A(5)">(5)</span> Amphetamines.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.06#B">B.</span> An appointing authority may submit to the Secretary a written request for approval to screen for a drug or controlled substance other than those listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.06#A" title="">§A of this regulation</a>. If the Secretary approves the request, the Secretary shall notify all appointing authorities who require testing for illegal use of drugs of the addition of that drug to the list.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.07" data-order="|17|04|09|.07|" data-ref-path="17|04|09|.07" class="h__section">.07 Testing Methodologies.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.07#A">A.</span> The initial screening test shall use an immunoassay.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.07#B">B.</span> The confirmatory test shall be gas chromatography-mass spectroscopy (GC-MS).</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.08" data-order="|17|04|09|.08|" data-ref-path="17|04|09|.08" class="h__section">.08 Testing Cutoff Levels.</h2>
                <p>An initial screening test result shall be determined to be positive based upon the following cutoff levels:</p>
                <p>Initial Test Level — nanograms per milliliter:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.08#A">A.</span> Marijuana metabolites — 50;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.08#B">B.</span> Cocaine metabolites — 300;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.08#C">C.</span> Opiate metabolites — 300;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.08#D">D.</span> Phencyclidine — 25;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.08#E">E.</span> Amphetamines — 1,000.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.09" data-order="|17|04|09|.09|" data-ref-path="17|04|09|.09" class="h__section">.09 Confirmatory Test.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.09#A">A.</span> A confirmatory test which uses the chromatography technology specified in <a class="internal-link " href="/us/md/exec/comar/17.04.09.07" title=".07 Testing Methodologies.">Regulation .07 of this chapter</a> shall be required subsequent to each test that produces positive results for any of the drugs listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.06" title=".06 Drugs to be Screened.">Regulation .06 of this chapter</a> or any drug which has been added to the list.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.09#B">B.</span> Protocols that double-screen are permitted only if test results which are positive on both screens are confirmed positive with GC-MS before reporting a positive test.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.09#C">C.</span> Protocols that result in one negative screening test shall be reported as a negative test.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.10" data-order="|17|04|09|.10|" data-ref-path="17|04|09|.10" class="h__section">.10 Testing Laboratory.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.10#A">A.</span> An appointing authority may arrange for collection of urine specimens by a contractor selected by the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.10#B">B.</span> Selection of a Laboratory by Appointing Authority. An appointing authority shall arrange for testing for illegal use of drugs to be conducted by a laboratory whose services have been contracted by the Secretary, and which is certified under National Institute of Drug Abuse Mandatory Guidelines for Federal Workplace Drug Testing Programs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.11" data-order="|17|04|09|.11|" data-ref-path="17|04|09|.11" class="h__section">.11 Approval of Testing Procedures; Statistics.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.11#A">A.</span> Each appointing authority shall establish a procedure for testing for illegal use of drugs, provided that the procedure is in accordance with this chapter. Before implementing that procedure, the appointing authority shall submit the following to the Secretary for approval:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.11#A(1)">(1)</span> A list of sensitive classifications for which random testing will be required;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.11#A(2)">(2)</span> A description of the testing procedure to be used; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.11#A(3)">(3)</span> The name of the laboratory that will conduct the testing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.11#B">B.</span> Each appointing authority shall designate an agency technical representative, and shall notify the Secretary in writing of the agency technical representative's name and position.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.11#C">C.</span> Each appointing authority shall submit to the Secretary periodic reports, including statistical information, in a format and according to a schedule determined by the Secretary.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.12" data-order="|17|04|09|.12|" data-ref-path="17|04|09|.12" class="h__section">.12 Annual Review.</h2>
                <p>The Secretary shall conduct an annual review of the program for testing for illegal use of drugs to:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.12#A">A.</span> Allow for incorporation of modifications made in the field of testing for illegal use of drugs;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.12#B">B.</span> Allow for addition or deletion of specific substances listed in <a class="internal-link " href="/us/md/exec/comar/17.04.09.06" title=".06 Drugs to be Screened.">Regulation .06 of this chapter</a>; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.12#C">C.</span> Ensure compliance with this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.13" data-order="|17|04|09|.13|" data-ref-path="17|04|09|.13" class="h__section">.13 Training.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.13#A">A.</span> Each appointing authority shall assure that training is provided to all of the appointing authority's employees who are involved in the implementation of this chapter. All training programs shall be subject to prior approval of the Secretary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.13#B">B.</span> Training shall include, but is not limited to, all of the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.13#B(1)">(1)</span> Conditions for testing for illegal use of drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.13#B(2)">(2)</span> Identification of sensitive classifications or sensitive positions, which require random testing for illegal use of drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.13#B(3)">(3)</span> Notification procedures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.13#B(4)">(4)</span> Testing protocols, including specimen collection and chain of custody;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.13#B(5)">(5)</span> Impact of positive test results upon applicants, employees, and the appointing authority;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.13#B(6)">(6)</span> Appeal rights; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/17.04.09.13#B(7)">(7)</span> Confidentiality requirements.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.14" data-order="|17|04|09|.14|" data-ref-path="17|04|09|.14" class="h__section">.14 Confidentiality.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.14#A">A.</span> Notwithstanding any regulation to the contrary, and to the extent permissible under applicable statutes, all test results shall be handled as confidential information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.14#B">B.</span> Test results shall be considered part of the employee's personnel record and subject to the confidentiality protections of State Government Article,</p>
                <p>§10-616(h), Annotated Code of Maryland, and <a class="internal-link no-wrap" href="/us/md/exec/comar/17.04.14" title="Chapter 14 Maintenance and Inspection of Records">COMAR 17.04.14</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.14#C">C.</span> Except for those persons identified elsewhere in these regulations as having a right of access to test results, only those members of management who have a need to know of test results shall be made aware of any test results.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/17.04.09.15" data-order="|17|04|09|.15|" data-ref-path="17|04|09|.15" class="h__section">.15 Notice of Regulations in this Chapter.</h2>
                <p>Each appointing authority shall assure that the appointing authority's employees are notified of the following:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.15#A">A.</span> The existence of these regulations;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.15#B">B.</span> The circumstances under which employees may be subject to these regulations; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/17.04.09.15#C">C.</span> The employees' rights to appeal any adverse action which results from the implementation of these regulations.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/17.04.08" aria-label="Chapter 08 Employee Rights and Protections">
                <div class="h__ui">Previous</div>
                <span>Chapter 08 Employee Rights and Protections</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/17.04.10" aria-label="Chapter 10 Training and Awards">
                <div class="h__ui">Next</div>
                <span>Chapter 10 Training and Awards</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
